Discover 3,043 paid clinical trials in Thousand Oaks, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,043
A Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005)
for
Healthy
Location: Anaheim CA
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18 - 55
Code: NCT07697625
Phase 1, Recruiting
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Duarte CA, Goodyear AZ, Houston TX, St Louis MO,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07594106
Phase 1, Phase 2, Recruiting
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
Location: Los Angeles CA, Orange CA, Irvine CA, Sacramento CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07452458
Phase 3, Recruiting
Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer
for
Clinical Stage III Gastric Cancer AJCC v8,
Location: Los Angeles CA, Scottsdale AZ, Green Bay WI,
Sponsor: Academic and Community Cancer Research United
Sex: All
Age: 18+
Code: NCT04660760
Phase 2, Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
for
Urinary Bladder Neoplasms,
Location: Los Angeles CA, Torrance CA, Bakersfield CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06833073
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
for
Non-Muscle Invasive Bladder Cancer
Location: Los Angeles CA, Orange CA, San Diego CA, Lakewood CO,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06319820
Phase 3, Recruiting
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Location: Los Angeles CA, San Francisco CA, San Antonio TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06413680
Phase 1, Phase 2, Recruiting
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
for
Extrapulmonary Neuroendocrine Cancer (epNEC)
Location: Duarte CA, St Louis MO, Nashville TN, Knoxville TN,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07544654
Phase 3, Recruiting
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Location: Los Angeles CA, Phoenix AZ, Salt Lake City UT,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06634589
Phase 1, Phase 2, Recruiting
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Location: Los Angeles CA, Duarte CA, Salt Lake City UT, Aurora CO,
Sponsor: Iovance Biotherapeutics, Inc.
Sex: All
Age: 18 - 70
Code: NCT05727904
Phase 3, Recruiting
Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
for
Platinum-Sensitive Ovarian Cancer, Ovarian Cancer
Location: Duarte CA, Tigard OR, Waukesha WI, Morgantown WV,
Sponsor: Genmab
Sex: Female
Age: 18+
Code: NCT07564141
Phase 3, Recruiting
MSC EVs in Dystrophic Epidermolysis Bullosa
for
Dystrophic Epidermolysis Bullosa
Location: Los Angeles CA, Phoenix AZ, Philadelphia PA
Sponsor: Aegle Therapeutics
Sex: All
Age: 0+
Code: NCT04173650
Phase 1, Phase 2, Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors